Catalyst Pharmaceutical CPRX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's net income?
- Catalyst Pharmaceutical (CPRX) reported net income of $63.73M in Q1 2026.
- How has Catalyst Pharmaceutical's net income changed year-over-year?
- Catalyst Pharmaceutical's net income increased by 12.3% year-over-year, from $56.74M to $63.73M.
- What is the long-term trend for Catalyst Pharmaceutical's net income?
- Over 4 years (2021 to 2025), Catalyst Pharmaceutical's net income has grown at a 52.6% compound annual growth rate (CAGR), from $39.48M to $214.33M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.